Loading clinical trials...
Loading clinical trials...
Tranexamic Acid (TXA) is an antifibrolytic medication used in total hip and knee arthroplasty to reduce the need for intraoperative and postoperative blood transfusions. Limited research is available ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Gregory M Georgiadis MD
NCT07556263 · Hip Fractures (ICD-10 72.01-72.2)
NCT05246813 · Osteoporosis, Osteoarthritis, Hip, and more
NCT06565910 · Femoral Neck Fractures, Femur Head Necrosis, and more
NCT07432737 · Hip Fractures
NCT06521671 · Femoral Neck Fractures, Internal Fixation; Complications, and more
ProMedica Toledo Hospital
Toledo, Ohio
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions